Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Agilon Health (AGL) EBITDA Margin: 2020-2025

Historic EBITDA Margin for Agilon Health (AGL) over the last 6 years, with Q3 2025 value amounting to 8.88%.

  • Agilon Health's EBITDA Margin rose 1100.0% to 8.88% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.16%, marking a year-over-year decrease of 1400.0%. This contributed to the annual value of 4.62% for FY2024, which is 5700.0% up from last year.
  • Latest data reveals that Agilon Health reported EBITDA Margin of 8.88% as of Q3 2025, which was up 1100.0% from 8.04% recorded in Q2 2025.
  • In the past 5 years, Agilon Health's EBITDA Margin ranged from a high of 0.2% in Q1 2023 and a low of 59.68% during Q2 2021
  • For the 5-year period, Agilon Health's EBITDA Margin averaged around 8.76%, with its median value being 4.05% (2022).
  • Per our database at Business Quant, Agilon Health's EBITDA Margin tumbled by -594200bps in 2021 and then surged by 566300bps in 2022.
  • Quarter analysis of 5 years shows Agilon Health's EBITDA Margin stood at 17.02% in 2021, then rose by 16bps to 14.3% in 2022, then fell by -7bps to 15.33% in 2023, then soared by 55bps to 6.88% in 2024, then decreased by -29bps to 8.88% in 2025.
  • Its EBITDA Margin stands at 8.88% for Q3 2025, versus 8.04% for Q2 2025 and 1.19% for Q1 2025.